Acute Urinary Retention: Clinical Trials

3 trials for Acute Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Not yet recruiting 1

Follow Acute Urinary Retention: new trials by email Literature Review of Acute Urinary Retention trials Research Report on Acute Urinary Retention

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention
Tamsulosin 0.4 mg, Tamsulosin 0.8 mg, Silodosin 8 mg - Acute Urinary Retention, Benign Prostatic Hyperplasia
Phase 4RecruitingBeni-Suef University3782026-06-082026-06-16
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
Tamsulosin, Tadalafil, Tadalafil Placebo - Acute Urinary Retention, Benign Prostatic Hyperplasia
Phase 4RecruitingBeni-Suef University3202026-06-082026-06-17
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy
Tamsulosin 0.2mg - Acute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)
Phase 4Not yet recruitingPeking University First Hospital18442026-02-012025-12-23

Narrower conditions

Prostatic Hyperplasia (2)  ·  Lower Urinary Tract Symptoms (1)

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Male Urogenital Diseases (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Urological Manifestations (1)

Interventions

Tamsulosin (3)  ·  Tadalafil (1)  ·  silodosin (1)

Sponsors

Beni-Suef University (2)  ·  Peking University First Hospital (1)

Countries

Egypt (2)  ·  China (1)